PENTIMALLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 424
EU - Europa 329
AS - Asia 40
SA - Sud America 1
Totale 794
Nazione #
US - Stati Uniti d'America 424
GB - Regno Unito 116
IE - Irlanda 80
RU - Federazione Russa 28
SE - Svezia 26
UA - Ucraina 25
CN - Cina 20
DE - Germania 18
SG - Singapore 15
IT - Italia 13
FR - Francia 10
BE - Belgio 8
FI - Finlandia 4
IN - India 3
BO - Bolivia 1
ES - Italia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 794
Città #
Southend 108
Dublin 80
Fairfield 67
Ann Arbor 56
Woodbridge 38
Chandler 32
Cambridge 28
Seattle 25
Houston 23
Wilmington 23
Ashburn 22
Jacksonville 21
Menlo Park 18
Singapore 11
New York 10
Brussels 8
Princeton 7
Boardman 4
Fort Worth 4
San Diego 4
Beijing 3
Delhi 3
Hebei 3
Shanghai 3
Venezia 3
Helsinki 2
Jiaxing 2
Moscow 2
Nanchang 2
Nanjing 2
Rome 2
San Mateo 2
Siena 2
Böblingen 1
Changsha 1
Düsseldorf 1
Hangzhou 1
Kunming 1
La Paz 1
Málaga 1
Pozza 1
Redwood City 1
Santa Clara 1
Shenyang 1
Tashkent 1
Tianjin 1
Totale 633
Nome #
NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer 206
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma 191
Antitumoral potential, antioxidant activity and carotenoid content of two Southern Italy tomato cultivars extracts: San Marzano and Corbarino 189
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition 132
RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines 50
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 39
Totale 807
Categoria #
all - tutte 2.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 16 14 14 21 16 8 4 12
2020/2021110 3 12 4 10 5 12 4 21 11 15 7 6
2021/202270 4 13 3 2 8 0 9 3 6 6 6 10
2022/2023132 7 10 17 15 12 41 6 8 11 1 4 0
2023/202481 3 1 3 4 1 29 36 0 0 0 0 4
2024/202547 4 5 25 8 5 0 0 0 0 0 0 0
Totale 807